Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Luo

Showing results (1121-1130 of 1,188) with videos related to

Pageof 119
Sort By:
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Lancet (London, England)|December 3, 2021
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trialSimon J Bowman, Robert Fox, Thomas Dörner, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 2, 2023
Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion-Weighted MR Imaging: An Externally Validated Machine Learning AlgorithmYang Guo, Zeyu Ma, Dongling Pei, et al.
CNS Neuroscience & Therapeutics|April 12, 2024
Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axisYuning Qiu, Dongling Pei, Minkai Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging StudyThomas Dörner, Simon J Bowman, Robert Fox, et al.
Endocrine|July 30, 2024
Clinical application potential of large language model: a study based on thyroid nodulesShujun Xia, Qing Hua, Zihan Mei, et al.
The Lancet. Infectious Diseases|July 29, 2021
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialShipo Wu, Jianying Huang, Zhe Zhang, et al.
Virology Journal|June 3, 2014
Porcine circovirus type 2 in China: an update on and insights to its prevalence and controlShao-Lun Zhai, Sheng-Nan Chen, Zhi-Hong Xu, et al.
Redox Biology|January 7, 2024
Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m<sup>6</sup>A-YTHDF2-dependent mannerZhi-Jun Yang, Si-Yu Huang, Kai-Yi Zhong, et al.
Pageof 119

Showing results (1121-1130 of 1,188) with videos related to

Sort By:
Pageof 119
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Lancet (London, England)|December 3, 2021
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trialSimon J Bowman, Robert Fox, Thomas Dörner, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 2, 2023
Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion-Weighted MR Imaging: An Externally Validated Machine Learning AlgorithmYang Guo, Zeyu Ma, Dongling Pei, et al.
CNS Neuroscience & Therapeutics|April 12, 2024
Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axisYuning Qiu, Dongling Pei, Minkai Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging StudyThomas Dörner, Simon J Bowman, Robert Fox, et al.
Endocrine|July 30, 2024
Clinical application potential of large language model: a study based on thyroid nodulesShujun Xia, Qing Hua, Zihan Mei, et al.
The Lancet. Infectious Diseases|July 29, 2021
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialShipo Wu, Jianying Huang, Zhe Zhang, et al.
Virology Journal|June 3, 2014
Porcine circovirus type 2 in China: an update on and insights to its prevalence and controlShao-Lun Zhai, Sheng-Nan Chen, Zhi-Hong Xu, et al.
Redox Biology|January 7, 2024
Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m<sup>6</sup>A-YTHDF2-dependent mannerZhi-Jun Yang, Si-Yu Huang, Kai-Yi Zhong, et al.
Pageof 119